Current position:Home >Product >
4(3H)-Quinazolinone, 3-[[1,2-dihydro-1-(4-morpholinylmethyl)-2-oxo-3H-indol-3-ylidene]amino ]-2-phenyl-
4(3H)-Quinazolinone, 3-[[1,2-dihydro-1-(4-morpholinylmethyl)-2-oxo-3H-indol-3-ylidene]amino ]-2-phenyl-(160421-10-3)
- Name: 4(3H)-Quinazolinone, 3-[[1,2-dihydro-1-(4-morpholinylmethyl)-2-oxo-3H-indol-3-ylidene]amino ]-2-phenyl-
- Synonyms:
- Molecular Formula:C27H23N5O3
- Molecular Weight:
- CAS Registry Number:160421-10-3
- EINECS:
- Melting Point:
- Water Solubility:
CAS No.160421-10-3 4(3H)-Quinazolinone, 3-[[1,2-dihydro-1-(4-morpholinylmethyl)-2-oxo-3H-indol-3-ylidene]amino ]-2-phenyl-
Assay:99.90% Appearance:solid or liquid Package:Foil bag; Drum; Plastic bottle Storage:in sealed air resistant place Transportation:by sea or air Application:Pharma;Industry;Agricultural
Min. Order:0
Supplier:Kono Chem Co.,Ltd [
China (Mainland)]
Other Product
- 160384-19-0/Urea, N-(2-hydroxy-4-methoxyphenyl)-N'-[3-(trifluoromethyl)phenyl]-
- 160384-22-5/Benzoic acid, 4-hydroxy-3-[[[[3-(trifluoromethyl)phenyl]amino]carbonyl]amino]-, methyl ester
- 160388-25-0/2-Oxa-3,9,14,20,25,31-hexaazadotriacontan-32-oic acid, 3-acetyl-10,13,21,24-tetraoxo-14,25-bis(phenylmethoxy)-, 1,1-dimethylethyl ester
- 160388-51-2/Benzeneacetic acid, 4-(1H-pyrazol-1-ylmethyl)-
- 160390-12-5/Butane, 2-methyl-2-(methylsulfinyl)-
- 160391-26-4/Propyldioxy, 2,2-difluoro-
- 160399-45-1/Thymidine, 3'-azido-5-bromo-3'-deoxy-6-ethoxy-5,6-dihydro-, (5S,6S)-
- 16040-77-0/Propanedioic acid, praseodymium(3+) salt (3:2), hexahydrate
- 160412-67-9/Phenol, 4-[(1R,3S)-2,2-dichloro-1-[4-[2-(dimethylamino)ethoxy]phenyl]-3-phenyl cyclopropyl]-, rel-
- 160413-14-9/Cyclohexene, 1,5,5-trimethyl-6-(3-methyl-2-penten-4-ynylidene)-
- 160421-10-3/4(3H)-Quinazolinone, 3-[[1,2-dihydro-1-(4-morpholinylmethyl)-2-oxo-3H-indol-3-ylidene]amino ]-2-phenyl-
- 160421-11-4/4(3H)-Quinazolinone, 3-[[1,2-dihydro-2-oxo-1-(1-piperidinylmethyl)-3H-indol-3-ylidene]amino]- 2-phenyl-
- 160421-12-5/4(3H)-Quinazolinone, 3-[[1-[(dicyclohexylamino)methyl]-1,2-dihydro-2-oxo-3H-indol-3-ylidene] amino]-2-phenyl-
- 160421-16-9/4(3H)-Quinazolinone, 3-[[1-[(dicyclohexylamino)methyl]-1,2-dihydro-5-methyl-2-oxo-3H-indol- 3-ylidene]amino]-2-phenyl-
- 160421-17-0/4(3H)-Quinazolinone, 3-[[1-[[bis(2-hydroxyethyl)amino]methyl]-1,2-dihydro-5-methyl-2-oxo-3H- indol-3-ylidene]amino]-2-phenyl-
- 160421-20-5/4(3H)-Quinazolinone, 3-[[1-[[bis(2-hydroxyethyl)amino]methyl]-5-bromo-1,2-dihydro-2-oxo-3H- indol-3-ylidene]amino]-2-phenyl-
- 160422-27-5/4(3H)-Quinazolinone, 3-[(acetyloxy)amino]-2-(1-methylethyl)-
- 16042-64-1/2-Furancarboxaldehyde, 5-nitro-, 2-pyridinylhydrazone
- 160427-96-3/Propanedioic acid, (1R)-2-cyclohepten-1-yl-, dimethyl ester
- 160428-34-2/5H-Cyclooct[b]indol-2-ol, 6,7,8,9,10,11-hexahydro-5-methyl-
- 160428-36-4/5H-Cyclooct[b]indol-2-ol, 6,7,8,9,10,11-hexahydro-
- 160429-78-7/1,2,4-Triazine-4(5H)-carboxamide, N,N-dimethyl-3-(methylthio)-5-oxo-6-phenyl-
- 160430-06-8/Methanone, [4,5-dihydro-2-phenyl-5-[(trimethylsilyl)methyl]-3-furanyl]phenyl-
- 160430-07-9/4(2H)-Benzofuranone, 3,5,6,7-tetrahydro-2-[(trimethylsilyl)methyl]-
- 160430-08-0/3-Furancarboxylic acid, 4,5-dihydro-2-methyl-5-[(trimethylsilyl)methyl]-, ethyl ester
- 160430-59-1/Spiro[9H-fluorene-9,3'-[3H]naphtho[2,1-b]pyran]
- 16043-38-2/Ethanamine, 2,2'-sulfonylbis[N-hydroxy-N-methyl-
- 160436-23-7/2H-Pyran, tetrahydro-2-[(3Z)-3-octenyloxy]-
- 16044-05-6/Methylium, bis[4-(dimethylamino)phenyl](4-nitrophenyl)-
- 16038-58-7/Stannate(1-), trichlorodimethyl-